IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

WordPress

LetsEncrypt

Chief Technology Officer and Co-Founder

Adam Sciambi

Chief Financial Officer

Marcel Roche

Assoc. Director Strategic Alliance

Nathan Testa

Chief Medical Officer

Todd Druley, MD, PhD

Chief Executive Officer

Yan Zhang

Marketing and Product

Anjali Pradhan

Sr VP Sales and Support

George Kopitas

Vice President, Marketing

Hannah Viernes

Vice President Operations

Hannah Yuan

Vice President of Bioinformatics

Hsiao-Mei Lu

Elias Rubel

Lu Zhang

William (Bill) Hyun

Robert Ghenchev

Maneesh Jain

Todd Druley

Co-Founder and VP of Technology

Brian Kim

CEO and Executive Board Member

Roman Haehn

Chief Commercial Officer

United States Late Stage Companies With More Than 100 Employees

Western US Late Stage Companies With More Than 100 Employees

Western US Startups (Top 10K)

West Coast Companies With More Than 50 Employees (Top 10K)

Mission Bio delivers targeted solutions for high-impact applications with the Tapestri Platform. The Tapestri Platform is the industry’s first and only single-cell multi-omics platform, enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. Application areas include oncology blood cancers, solid tumors, and genome editing validation.

Debt Financing - Mission Bio

Novo Holdings

Series C - Mission Bio

Series B - Mission Bio

Venture Round - Mission Bio

Mayfield Fund

Series A - Mission Bio

National Science Foundation

Grant - Mission Bio

San Francisco

California

United States

North America

Mission Bio

Mission Bio Appoints Roman Haehn as Chief Commercial Officer to Drive Market Expansion

Logo - Mission Bio Appoints Roman Haehn as Chief Commercial Officer to Drive Market Expansion

Mission Bio Announces Launch of First Single-Cell Multiple Myeloma Multiomics Solution Aimed to Transform ...

Mission Bio's Tapestri Platform Unveils Insights into Targeted Therapy and Residual Disease Assessment for Multiple ...

Single-cell Omics Market to Attain Valuation US$ 35.11 billion by 2033

Single-cell Omics Market Size to Worth Around USD 9.65 Bn by 2033

Todd Druley, MD, PhD on LinkedIn: Single-Cell Multiomics Is Advancing Cancer Research

A platform for single-cell DNA and protein multiomic analysis, enabling the detection of rare cell populations and the study of therapeutic resistance and response.

Technology for detecting rare clonal populations and identifying genetic aberrations at the single-cell level.

Integrates DNA and protein data from the same cell for a comprehensive multi-omics analysis.

Service for designing custom assays tailored to specific experimental needs.

Comprehensive support for drug and therapeutic development, including experimental design, assay execution, and data interpretation.

Features that allow the combination of several samples in a single run to reduce costs and increase throughput for single-cell analysis.

Germany

Europe

Kenya

Africa

United Kingdom

France

HTML5

Google Analytics

Google Compute Engine

Fonts.com

Fastly

Wordpress

Amazon EC2

Adobe Flash

jQuery

Mission Bio provides cancer researchers with single-cell technology that simultaneously measures single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. Their multi-omics platform connects genotype and phenotype in each cell, dissecting the architecture of tumors with unprecedented resolution.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 8:48 PM	fd9cd545
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 8:48 PM	18765057
company summary	general
signals	general
crunchbase trigger	general	Nov 18, 2024 2:12 PM	b0989400
crunchbase profile	general	Nov 19, 2024 12:06 PM	99817ed1
li profile	general
translate crunchbase fundingrounds	general	Nov 19, 2024 2:20 PM	54150385
peers	general
news basic	general	Mar 8, 2024 8:48 PM	dd18b8c2
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

MISS

COM:MISSIONBIO

Mission Bio